Cargando…

Advances and challenges of immunocheckpoint inhibitors in the treatment of primary liver cancer

Primary liver cancer (PLC) is one of the most common malignant tumors, which clinically characterized by occult onset, rapid development, easy recurrence and poor prognosis. With the rapid development of tumor immunotherapy research, tumor immunotherapy has also achieved remarkable clinical efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Meng, Yao, Weirong, Shen, Qinglin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561712/
https://www.ncbi.nlm.nih.gov/pubmed/36246617
http://dx.doi.org/10.3389/fgene.2022.1005658

Ejemplares similares